immunity News and Research

RSS

Georgia State researcher receives award to investigate the influence of environment on IBD

Dr. Michal Kuczma, a research assistant professor in the Institute for Biomedical Sciences at Georgia State University, has received a three-year, $270,000 Career Development Award from the Crohn's and Colitis Foundation to study environmental influences on gut microbiota, immunity and inflammation.

4 Sep 2021

Can COVID-19 vaccines affect athletic performance in the short term?

Getting the COVID-19 vaccine — especially the second shot — can produce minor side effects such as aches and fever that tend to go away after a day or two. Adding to the list, a small study from the University of Arizona found that people may find it slightly challenging to exercise after getting a two-dose coronavirus vaccine.

3 Sep 2021

Antibody cocktail neutralizes SARS-CoV-2 and has projected protection up to 12 months

A new study reports long-lasting, effective protection against severe disease with the AZD7442 antibody cocktail.

3 Sep 2021

Study finds link between COVID-19 vaccine hesitancy and vaccine passports

A new study from Imperial College London has found a link between COVID-19 vaccine hesitancy and a perceived lack of free will over vaccine passports.

2 Sep 2021

World renowned immunologist named chief of Feinberg's Division of Allergy and Immunology

Stephanie Eisenbarth, MD, PhD, has been named chief of Feinberg's Division of Allergy and Immunology in the Department of Medicine, and director of the newly formed Center for Human Immunobiology.

2 Sep 2021

Climate and COVID-19 spread

A new study examines whether the number of infections and the mortality due to the virus is related to the temperature, rainfall, sunlight, and ultraviolet index (UVI).

2 Sep 2021

Adaptive policies integrating vaccination effort is key to relaxing restrictions during COVID-19 infection waves

Study suggests that re-opening countries and relaxing preventative measures safely is closely associated with vaccination efforts.

2 Sep 2021

Booster shot of Pfizer COVID-19 vaccine provides additional protection against SARS-CoV-2 infection

A team of scientists from the USA and Israel has recently highlighted the importance of a third booster dose of the Pfizer/BioNTech coronavirus disease 2019 (COVID-19) vaccine in achieving additional protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the medRxiv* preprint server.

2 Sep 2021

Study identifies how immune sensors launch a multi-faceted innate immune response to infections

St. Jude Children's Research Hospital immunologists have identified how immune sensors in infected cells organize and launch a multi-faceted innate immune response to infections with live viruses and bacteria. The discovery appears today in Nature.

2 Sep 2021

Newly discovered cell type makes survivors of sepsis more vulnerable to infections

Sepsis is the leading cause of death in Brazil's intensive care units (ICUs). Among patients who progress to the severe form of the disease, 40% die, and the survivors often suffer from cardiovascular and neurological complications, as well as a significant decline in immunity lasting for years after they are discharged from hospital.

2 Sep 2021

An assessment of post-vaccination immune response to SARS-CoV-2 Delta in elderly and health care workers

A new cohort study comparing immune responses among vaccinated elderly persons and healthcare workers has been conducted.

2 Sep 2021

Experts show waning effectiveness of COVID-19 vaccines over time

In a letter to The New England Journal of Medicine, publishing online September 1, 2021, an interdisciplinary team of physicians and public health experts at University of California San Diego measured the effectiveness of COVID-19 mRNA vaccines among health workers at UC San Diego Health, most notably during the emergence of the highly transmissible delta virus variant and coincident with the end of the state's mask mandate, allowing fully vaccinated persons to forgo face coverings in most places.

1 Sep 2021

Do kidney transplant recipients need a third booster dose of mRNA COVID-19 vaccine?

A team of researchers in France have observed that the “standard” 2 dose regimen for mRNA COVID-19 vaccines could provide adequate protection to only a few KTRs. It has also been shown in multiple studies that a considerable population of vaccinated KTRs were easily infected with SARS-CoV-2.

1 Sep 2021

Can barrier gestures be relaxed without causing a COVID-19 resurgence in France?

A new study focused on determining the magnitudes of a barrier gesture relaxation in France. Read more here.

1 Sep 2021

New candidate vaccine for COVID-19 found to be efficacious in preclinical models

More than a year after the start of the COVID-19 pandemic, several vaccines have been authorized thanks to unprecedented worldwide research efforts. These first-generation vaccines bring great hope and are a mainstay in fighting the virus.

1 Sep 2021

Baylor researchers use a faster, more cost-effective technology to discover SARS-CoV-2 inhibitor

Much progress has been made on the development of vaccines aiming at triggering human immunity to SARS-CoV-2, the virus that causes COVID-19. In addition, researchers at Baylor College of Medicine are involved in the development of antiviral drugs to treat infected individuals.

1 Sep 2021

A global genetic surveillance gap for SARS-CoV-2

Now a new study posted to the medRxiv* preprint server provides a perspective on the global disparities surrounding SARS-CoV-2 genomic surveillance, their causes and consequences, and possible solutions to maximize the impact of pathogen genome sequencing for efforts on public health.

1 Sep 2021

Increased transmissibility drives SARS-CoV-2 variant spread, aided by immune escape

Numerous variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged over the last few months. Unfortunately, this has driven new coronavirus disease 2019 (COVID-19) waves, often more severe than before. A recent study posted to the medRxiv* preprint server discusses the characteristics of the variant that is responsible for this phenomenon.

31 Aug 2021

Attenuated virulence and protective immunity in SARS-CoV-2 with a mutation in the S1/S2 cleavage site

A new study published in mBio investigates the impact of the furin cleavage site on viral growth and pathogenesis.

31 Aug 2021

Development of SARS-CoV-2 antibody escape variants in an immunocompromised individual

A new study published in mBio discusses the microevolution of SARS-CoV-2.

31 Aug 2021

immunity News and Research

Georgia State researcher receives award to investigate the influence of environment on IBD

Can COVID-19 vaccines affect athletic performance in the short term?

Antibody cocktail neutralizes SARS-CoV-2 and has projected protection up to 12 months

Study finds link between COVID-19 vaccine hesitancy and vaccine passports

World renowned immunologist named chief of Feinberg's Division of Allergy and Immunology

Climate and COVID-19 spread

Adaptive policies integrating vaccination effort is key to relaxing restrictions during COVID-19 infection waves

Booster shot of Pfizer COVID-19 vaccine provides additional protection against SARS-CoV-2 infection

Study identifies how immune sensors launch a multi-faceted innate immune response to infections

Newly discovered cell type makes survivors of sepsis more vulnerable to infections

An assessment of post-vaccination immune response to SARS-CoV-2 Delta in elderly and health care workers

Experts show waning effectiveness of COVID-19 vaccines over time

Do kidney transplant recipients need a third booster dose of mRNA COVID-19 vaccine?

Can barrier gestures be relaxed without causing a COVID-19 resurgence in France?

New candidate vaccine for COVID-19 found to be efficacious in preclinical models

Baylor researchers use a faster, more cost-effective technology to discover SARS-CoV-2 inhibitor

A global genetic surveillance gap for SARS-CoV-2

Increased transmissibility drives SARS-CoV-2 variant spread, aided by immune escape

Attenuated virulence and protective immunity in SARS-CoV-2 with a mutation in the S1/S2 cleavage site

Development of SARS-CoV-2 antibody escape variants in an immunocompromised individual

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News